Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.36 USD | -0.74% | -13.22% | -23.06% |
Financials (USD)
Sales 2024 * | 293M | Sales 2025 * | 354M | Capitalization | 1.65B |
---|---|---|---|---|---|
Net income 2024 * | -180M | Net income 2025 * | -159M | EV / Sales 2024 * | 5.04 x |
Net cash position 2024 * | 174M | Net cash position 2025 * | 139M | EV / Sales 2025 * | 4.27 x |
P/E ratio 2024 * |
-9.29
x | P/E ratio 2025 * |
-10.8
x | Employees | 919 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.22% |
Latest transcript on Twist Bioscience Corporation
1 day | -0.74% | ||
1 week | -13.22% | ||
Current month | -17.34% | ||
1 month | -16.17% | ||
3 months | -16.22% | ||
6 months | +65.36% | ||
Current year | -23.06% |
Managers | Title | Age | Since |
---|---|---|---|
William Banyai
FOU | Founder | 69 | 13-02-03 |
Emily Leproust
CEO | Chief Executive Officer | 50 | 13-03-31 |
Adam Laponis
DFI | Director of Finance/CFO | 47 | Jan. 04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Ragusa
BRD | Director/Board Member | 64 | 16-10-31 |
Jan Johannessen
BRD | Director/Board Member | 67 | 18-09-30 |
Keith Crandell
BRD | Director/Board Member | 63 | 13-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.68% | 1 M€ | 0.00% | - | |
1.87% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 28.36 | -0.74% | 807,821 |
24-04-17 | 28.57 | -0.14% | 837,768 |
24-04-16 | 28.61 | -2.15% | 871,062 |
24-04-15 | 29.24 | -4.69% | 864,282 |
24-04-12 | 30.68 | -6.12% | 1,092,011 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.06% | 1.65B | |
-5.32% | 84.57B | |
+3.95% | 39.93B | |
-26.37% | 27.93B | |
+52.09% | 24.21B | |
-6.59% | 17.17B | |
-32.37% | 13.93B | |
-10.45% | 12.3B | |
-15.88% | 11.84B | |
-2.85% | 7.91B |
- Stock Market
- Equities
- TWST Stock